Directory
>
Marcus Hompesch
Marcus Hompesch
CEO & Chairman of the Board | ProSciento, Inc.
San Diego, California, United States
Marcus Hompesch
Summary
Marcus Hompesch is a seasoned CEO and Chairman of the Board at ProSciento, Inc., specializing in clinical research and drug development, particularly in diabetes and metabolic diseases. With a robust background in internal medicine, he transitioned from clinical practice to leading innovative clinical research organizations. His entrepreneurial spirit led him to establish multiple companies focused on diabetes management technologies. Marcus has a strong commitment to advancing clinical research methodologies that drive meaningful outcomes in early-phase studies. He has over 30 peer-reviewed publications, highlighting his dedication to scientific excellence. His leadership experience spans various roles, including COO and CEO, showcasing his adaptability and strategic vision in the healthcare sector. He is known for his expertise in clinical trials and regulatory submissions, making him a key player in the biotech industry. Marcus's work not only impacts the pharmaceutical landscape but also contributes to improving patient care in chronic disease management.
Marcus Hompesch
Work Experience
CEO & Chairman of the Board at
ProSciento, Inc.
January 2003 - Present
CEO at
Profil Outpatient Trials
January 2001 - December 2003
COO at
Profil Institute For Metabolic Research
September 2000 - December 2003
Founder and CEO at
MedIQ, s. r. o.
January 1999 - July 2000
Founder and CEO at
Mkd
January 1997 - January 1999
Physician at
Klinikum Wuppertal
June 1992 - September 1998
Scientific Associate at
Ruhr-Universität Bochum
January 1996 - January 1997
Marcus Hompesch
Education
University of Düsseldorf , M.D.
January 1986 - January 1992
Frequently Asked Questions about Marcus Hompesch
What is Marcus Hompesch email address?
Marcus Hompesch's primary email address is ***************@mac.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Marcus Hompesch work for?
Marcus Hompesch is a CEO & Chairman of the Board at ProSciento, Inc., a company specializing in Commercial physical research.
Where Marcus Hompesch graduated from?
Marcus Hompesch holds a degree in Medicine from University of Düsseldorf .
How can I directly contact Marcus Hompesch?
To contact Marcus Hompesch directly, you can use the email address ***************@mac.com. Complete contact information is available upon registration with Muraena.
Is Marcus Hompesch an immigrant?
Yes, Marcus Hompesch is an immigrant and currently based in United States
Who is Marcus Hompesch?
Marcus Hompesch is a seasoned CEO and Chairman of the Board at ProSciento, Inc., specializing in clinical research and drug development, particularly in diabetes and metabolic diseases. With a robust background in internal medicine, he transitioned from clinical practice to leading innovative clinical research organizations. His entrepreneurial spirit led him to establish multiple companies focused on diabetes management technologies. Marcus has a strong commitment to advancing clinical research methodologies that drive meaningful outcomes in early-phase studies. He has over 30 peer-reviewed publications, highlighting his dedication to scientific excellence. His leadership experience spans various roles, including COO and CEO, showcasing his adaptability and strategic vision in the healthcare sector. He is known for his expertise in clinical trials and regulatory submissions, making him a key player in the biotech industry. Marcus's work not only impacts the pharmaceutical landscape but also contributes to improving patient care in chronic disease management.
Marcus`s contact details
***************@mac.com
***************@profilinstitute.com
***************@prosciento.com
Colleagues
Sr. Director, Business Operations, Business Development / CRO Services (Remote)
Chief Financial Officer
Executive Director Quality & Regulatory Compliance
Project Manager I, CRO
Vice President, Global Business Development
Clinical Project Manager II, CRO Services
Executive Director, Patient and Site Services